Fundz

Oncoshot Receives Funding To Expand Cancer Data Sharing Capabilities For Hospitals And Industry

PRIVATEJul 14, 2022

Round Type

Funding Round

SingaporeHealth CareScience And Engineering

Description

Oncoshot today announced a pre-series A funding round led by MassMutual Ventures (MMV). Other investors for this stage come from a suite of healthtech veterans that include Milltrust International and health industry angel investors.

Quick answer

Oncoshot raised an undisclosed amount in a Funding Round round, dated July 14, 2022. Oncoshot is based in Singapore.

How much did Oncoshot raise?
Oncoshot raised an undisclosed amount in a Funding Round round on July 14, 2022.
What does Oncoshot do?
Oncoshot was founded in 2018 by Dr Huren Sivaraj, a medical oncologist, and Ruslan Enikeev, a data science engineer.
Where is Oncoshot based and how big is it?
Oncoshot is based in Singapore.

Source: Fundz verified event record.

Who else raised in Science And Engineering and Health Care around the same time

Companies in the same sectors as Oncoshot that raised within 45 days of this round, from Fundz verified event records.

  • Theriva Biologics raised $3M (Seed) on July 29, 2022.
  • Enveric Biosciences raised $8.6M on July 22, 2022.
  • Trait Biosciences Inc. raised $102K (Series A) on July 22, 2022.
  • 22nd Century raised $35M on July 21, 2022.
  • Camp4 Therapeutics Corp raised $100M (Series B) on July 20, 2022.
  • Agomab raised $41M (Series B) on July 13, 2022.

Who to call at Oncoshot, and when

A new round usually means Oncoshot is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Oncoshot raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Oncoshot, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Oncoshot. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Oncoshot

Location

Singapore

About

Oncoshot was founded in 2018 by Dr Huren Sivaraj, a medical oncologist, and Ruslan Enikeev, a data science engineer. Oncoshot's mission is to help oncologists identify cancer clinical trials more efficiently and effectively for patients and their caregivers by supporting hospitals and research partners. Its current focus is to leverage artificial intelligence technology to address the inefficiencies of cancer clinical trials. Oncoshot has expanded to Australia and India since its inception in Singapore, an act that highlights its applicability and success. For more information, visit https://www.oncoshot.com/.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Oncoshot raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Oncoshot's next move

See what Strategic adds

Oncoshot raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.